Geographical Variation in the Response of Visceral Leishmaniasis to Paromomycin in East Africa: A Multicentre, Open-Label, Randomized Trial

BACKGROUND: Visceral leishmaniasis (VL) is a major health problem in developing countries. The untreated disease is fatal, available treatment is expensive and often toxic, and drug resistance is increasing. Improved treatment options are needed. Paromomycin was shown to be an efficacious first-line...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hailu, Asrat, Musa, Ahmed, Wasunna, Monique, Balasegaram, Manica, Yifru, Sisay, Mengistu, Getahun, Hurissa, Zewdu, Hailu, Workagegnehu, Weldegebreal, Teklu, Tesfaye, Samson, Makonnen, Eyasu, Khalil, Eltahir, Ahmed, Osama, Fadlalla, Ahmed, El-Hassan, Ahmed, Raheem, Muzamil, Mueller, Marius, Koummuki, Yousif, Rashid, Juma, Mbui, Jane, Mucee, Geoffrey, Njoroge, Simon, Manduku, Veronica, Musibi, Alice, Mutuma, Geoffrey, Kirui, Fredrick, Lodenyo, Hudson, Mutea, Dedan, Kirigi, George, Edwards, Tansy, Smith, Peter, Muthami, Lawrence, Royce, Catherine, Ellis, Sally, Alobo, Moses, Omollo, Raymond, Kesusu, Josephine, Owiti, Rhoda, Kinuthia, John
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2010
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2964287/
https://ncbi.nlm.nih.gov/pubmed/21049059
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0000709
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars